Intellectual Property

  • March 30, 2026

    Justices Told Fed. Circ. Wrongly Axed Car ID Patent Claims

    A vehicle identification system patent owner wants the U.S. Supreme Court to review the Federal Circuit's reversal of the Patent Trial and Appeal Board's decision allowing the company to amend claims in two patents challenged by rideshare giant Lyft.

  • March 30, 2026

    Patent Monetization Co. Looks To Sink $32M Arbitration Award

    A patent monetization firm has sued a litigation funder and law firm Susman Godfrey LLP in Texas federal court, seeking to vacate an arbitration award that it says was riddled with errors.

  • March 30, 2026

    Former Intel Engineer Fights Trade Secret Suit

    A former Intel engineer has asked a Washington federal court to dismiss a lawsuit alleging he stole nearly 18,000 files before his employment was terminated in July, saying he wasn't properly notified of the case and responded promptly when he found out about it.

  • March 30, 2026

    Sanofi Claims IP Life Extension Needed For Double Patenting

    The Patent Trial and Appeal Board rightly found a Sanofi patent application shouldn't be rejected for obviousness-type double patenting, as it doesn't improperly extend patent life, the French drugmaker and its allies have told U.S. Patent and Trademark Office Director John Squires.

  • March 30, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court's docket this past week featured disputes involving globally recognized companies, high-dollar contract fights, revived claims from the state's high court and the resolution of a closely watched de-SPAC case.

  • March 30, 2026

    Fastener Co. Can't Slip $17K TM Infringement Judgment

    A Pennsylvania federal judge has upheld a $17,000 trademark infringement judgment against industrial fastener company Peninsula Components after it was found liable for using its competitor Penn Engineering & Manufacturing Corp's "PEM" name in Google Ads, ruling that the defendant presented no compelling reason to erase the verdict.

  • March 30, 2026

    Tilray Accused Of Dodging $11M In Bob Marley Royalties

    Multistate cannabis giant Tilray owes more than $11 million in royalty payments for using Bob Marley's brand in connection with marijuana products, according to a new lawsuit filed in Delaware Chancery Court.

  • March 30, 2026

    Hunter S. Thompson Whiskey Brand Sued Over IG Photos

    The owner of the copyright to pictures taken by Hunter S. Thompson's personal photographer claimed in Colorado federal court Monday that the whiskey brand owned by Thompson's estate violated copyright law by posting some of the photos on their social media.

  • March 30, 2026

    TriZetto's $70M Trade Secrets Verdict Upheld, Total Award Cut

    A New York federal judge has upheld a $70 million compensatory damages verdict for the TriZetto Group in a long-running trade secret fight against Syntel Inc., while also cutting punitive damages to about $140 million and awarding TriZetto more than $12 million in attorney fees.

  • March 30, 2026

    Del. Judge Upholds $34M Verdict In Glaucoma Patent Feud

    A Delaware federal judge has affirmed a $34 million verdict against Alcon and related entities for infringing patents covering medical devices to treat glaucoma, disagreeing that Sight Sciences Inc. had failed to show the accused product meets the limitations of the patent claims.

  • March 30, 2026

    Nationwide Need Not Cover Marker Makers' Trade Secret Fight

    Four Nationwide units have no duty to defend a marker manufacturer in an underlying suit by a competitor alleging it colluded with former employees to use trade secrets and other proprietary information, a Pennsylvania federal judge ruled.

  • March 30, 2026

    J&J Unit Wants Forensic Exam Of Ex-Director's Devices

    A Johnson & Johnson subsidiary urged a New Jersey federal court to order a former associate director to submit to a court-supervised forensic inspection of any device or account in which she could have stored confidential information it claims she downloaded in order to start her own competing company.

  • March 30, 2026

    Retailers Not Covered In Trademark Infringement Dispute

    An insurer has no duty to defend a home goods retailer accused of using another company's trademark in its online advertising and marketing, an Illinois federal court ruled, finding that the underlying suit does not allege a covered personal and advertising injury.

  • March 30, 2026

    High Court Turns Away CRISPR Patent Validity Dispute

    The U.S. Supreme Court on Monday rejected Agilent Technologies' bid to revive patents on the gene-editing tool CRISPR, which centers on the burden of proof in establishing prior art.

  • March 30, 2026

    Justices Reject TM Appeal Tied To 'Use In Commerce'

    The U.S. Supreme Court on Monday declined to take up an appeal challenging a Ninth Circuit ruling that upheld a multimillion-dollar default judgment based largely on statements defendants made in trademark applications.

  • March 27, 2026

    Injunction Constraints Impede Utility Patent Counterfeit Cases

    A Texas federal judge ruled this month that the strongest tool to stop counterfeiters in so-called Schedule A cases doesn't apply to utility patents, which attorneys say cements a long-standing practice of retailers relying on trademarks and design patents.

  • March 27, 2026

    Inventors Back Dolby's Interested-Party High Court Fight

    A group representing inventors and entrepreneurs is supporting Dolby's bid to have the U.S. Supreme Court review a Federal Circuit dismissal of the company's appeal of a Patent Trial and Appeal Board proceeding it won, citing the importance of knowing which parties are behind a patent challenge.

  • March 27, 2026

    Hemp Co. Seeks To Cancel Popular 'Lost Mary' Vape TM

    A North Carolina hemp provider is looking to cancel the popular "Lost Mary" vape trademark, held by the Chinese company that also sells Elf Bars, telling a California federal court that it was always invalid because it's illegal to sell flavored vapes.

  • March 27, 2026

    Eli Lilly Keeps Most Of Weight Loss Drug Copy Suit Alive

    A California federal judge has refused to throw out a lawsuit accusing a pair of telehealth companies of making copies of Eli Lilly's obesity and type 2 diabetes drugs but agreed to trim the case.

  • March 27, 2026

    NC Biz Court Bulletin: Judge Exits, Duke Ducks Climate Suit

    The North Carolina Business Court saw an unexpected shakeup with one judge's retirement, rendered a pivotal decision in a first-of-its-kind climate change case against Duke Energy and oversaw a trial between the feuding owners of a commercial bed skirt company.

  • March 27, 2026

    ITC Will Review Solar Cell Imports For Infringement

    The U.S. International Trade Commission is launching an investigation into claims by an Arizona-based solar company accusing nearly 50 companies of importing solar cells into the U.S. that infringe one of its patents.

  • March 27, 2026

    Skull Shaver Can't Stop NJ Judge From Moving IP Suit To NC

    A New Jersey federal judge has adopted the recommendation of a magistrate judge who said Skull Shaver's patent infringement case against The Cut Buddy over electronic razor technology could move to North Carolina federal court.

  • March 27, 2026

    Nobel Prize Winners Again Lose Patent Fight Over CRISPR

    The Patent Trial and Appeal Board has ruled against a pair of Nobel Prize-winning scientists in a patent dispute over who was the first to invent key aspects of the gene-editing technology CRISPR, siding again with a rival team from the Broad Institute and the Massachusetts Institute of Technology.

  • March 27, 2026

    Skincare Co. Says ITC Ruling Backs Ending PTAB Challenge

    Skin products company Hydrafacial has argued U.S. Patent and Trademark Office Director John Squires should turn down a rehearing request from rival Sinclair Pharma over Squires' order de-instituting a challenge to Hydrafacial's patent, saying a U.S. International Trade Commission decision upholding the same patent supports the director's move.

  • March 27, 2026

    6th Circ. Won't Revive Ky. Bourbon-Makers' Fight Over A 'First'

    A Kentucky distillery that claims to be the first African American-owned company to make bourbon at its own facility in the Bluegrass State can't revive its false advertising lawsuit against another distiller claiming the same distinction, the Sixth Circuit ruled in a Thursday published opinion.

Expert Analysis

  • Considering The Risks That Arise When IP Outlives Its Owner

    Author Photo

    Federal and state court decisions show that the statutory regime for each category of intellectual property promises continuity after the owner's death, but the law does not provide a succession framework for how those rights are to be exercised, says Erin Daly at Daly Law & Strategy.

  • How A High Court Music Piracy Ruling Shrinks ISP Liability

    Author Photo

    The U.S. Supreme Court's recent opinion in Cox Communications Inc. v. Sony Music Entertainment, which concerned the boundaries of contributory copyright infringement for internet service providers, dramatically lessens both the risk that an ISP will be held contributorily liable and, relatedly, the incentives an ISP may have to help combat online copyright infringement, say attorneys at Debevoise.

  • Opinion

    AI Presents A Make-Or-Break Moment For Outside Counsel

    Author Photo

    The rapid adoption of artificial intelligence by corporate legal departments is forcing a long-overdue reset of the relationship between inside and outside counsel, and introducing a significant opportunity to shed frustrating inefficiencies and strengthen collaboration for firms willing to embrace the shift, says Intel Chief Legal Officer April Miller Boise.

  • Opinion

    USPTO Has A Chance To Correct Double-Patenting Doctrine

    Author Photo

    Now that the issue of obviousness-type double patenting is front and center before the U.S. Patent and Trademark Office's Appeals Review Panel, the agency should put an end to the practice of rejecting earlier-expiring patents in favor of later-expiring ones, say attorneys at Orrick.

  • 1st AI Acquisition Regulation Raises Contractor Concerns

    Author Photo

    The General Services Administration’s recently published contract clause addressing artificial intelligence systems is problematic in a number of ways, underscoring the complex legal and practical issues that will need to be addressed as AI becomes more widely deployed in federal contracting, say attorneys at Haynes Boone.

  • Grammarly Suit Flags Right Of Publicity As Key AI Issue

    Author Photo

    Angwin v. Superhuman Platform, filed recently in New York federal court against the parent company of Grammarly, highlights an overlooked question for any company using artificial intelligence — whether someone's identity has been used for commercial purposes without consent, possibly violating rapidly shifting state right-of-publicity laws, says Nicholas Schneider at Eckert Seamans.

  • Series

    Watching Hallmark Movies Makes Me A Better Lawyer

    Author Photo

    I realize you may be judging me for watching, and actually enjoying, Hallmark Channel movies, but the escapism and storylines actually demonstrate qualities and actions that lead to an efficient, productive and positive legal practice, says Karen Ross at Tucker Ellis.

  • Reel Justice: 'Mercy' And Private Surveillance As Evidence

    Author Photo

    The near-future depicted in the film “Mercy” reminds attorneys that private surveillance networks are becoming central to the evidentiary ecosystem, shaping what prosecutors can obtain, what defendants must explain and what jurors may interpret as objective truth, says Veronica Finkelstein at Wilmington University.

  • Fed. Circ. In February: When Grammar Trumps Patent Specs

    Author Photo

    The Federal Circuit's decision in Netflix v. DivX last month highlights the challenge of interpreting potentially misplaced modifiers in complicated technological patents, and the potential for grammatical rules to provide a default interpretation for unclear claim language, say attorneys at Knobbe Martens.

  • New Orphan Drug Law Provides A Key Fix For Pharma Cos.

    Author Photo

    The Consolidated Appropriations Act enacted last month restores the U.S. Food and Drug Administration's long-standing interpretation of "same disease or condition," related to orphan drug exclusivity, resolving years of regulatory uncertainty and litigation that have discouraged rare disease research, say attorneys at Spencer Fane.

  • When Trade Secret Litigation And Criminal Law Collide

    Author Photo

    An increasing convergence of trade secret litigation and white collar defense, especially with several recent criminal prosecutions from the Justice Department, should prompt businesses and counsel to adapt within the overlapping landscapes, says Kenneth Notter at MoloLamken.

  • Opinion

    PTAB Needs Reform To Protect Inventors From Larger Cos.

    Author Photo

    The Promoting and Respecting Economically Vital American Innovation Leadership Act is necessary because it will impose additional requirements on patent validity challenges and prevent large corporations from taking advantage of the Patent Trial and Appeal Board to overwhelm small inventors with repeated litigation, says Eb Bright at ExploraMed Development.

  • Changes Coming To The SBIR And STTR Programs

    Author Photo

    Legislation recently approved by Congress to reauthorize the Small Business Innovation Research and Small Business Technology Transfer Programs includes changes focused on national security that would improve transparency but also increase applicants' administrative burdens, slow the awards process and likely increase litigation, say attorneys at Fluet & Associates.

  • Witness AI Usage Is The Next Privilege Battle In Civil Litigation

    Author Photo

    Fact and expert witnesses now have immediate access to artificial intelligence systems capable of simulating deposition questioning, recommending answers and more, but this preparation occurs privately, invisibly and frequently under the mistaken assumption that it is harmless, says Bill Kanasky at Courtroom Sciences and Billy Davis at Taylor Nelson.

  • Moderna Case Highlights Overlooked Hurdle In Biopharma IP

    Author Photo

    The recent settlement of the patent litigation involving Moderna's COVID-19 vaccine in Delaware federal court shows that patent portfolios covering enabling platform technologies can create significant freedom-to-operate risk even when their owners are not direct competitors developing the therapeutic product, says Olga Berson at Thompson Coburn.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here